Kang S Y, Schini-Kerth V B, Kim N D
College of Pharmacy, Seoul National University, Korea.
Life Sci. 1995;56(19):1577-86. doi: 10.1016/0024-3205(95)00124-o.
The vasoactive effects of several ginsenosides, purified from Panax ginseng, were tested in the rat aorta. Ginsenosides from the protopanaxatriol group and its purified ginsenosides Rg1 and Re cause endothelium dependent relaxation which is associated with the formation of cyclic GMP. Both responses to these protopanaxatriol-containing ginsenosides are inhibited by methylene blue, an inhibitor of soluble guanylate cyclase and of nitric oxide synthase. In contrast, ginsenosides from the protopanaxadiol group and its purified ginsenosides Rb1 and Re do not affect vascular tone or production of cyclic GMP in the rat aorta. These findings demonstrate that ginsenosides from the protopanaxatriol group but not from the protopanaxadiol group enhance the release of nitric oxide from endothelial cells and may contribute to the beneficial effect of ginseng on the cardiovascular system.
从人参中提纯的几种人参皂苷的血管活性作用在大鼠主动脉中进行了测试。原人参三醇组人参皂苷及其提纯的人参皂苷Rg1和Re可引起内皮依赖性舒张,这与环鸟苷酸(cGMP)的形成有关。对这些含原人参三醇的人参皂苷的两种反应均被亚甲蓝抑制,亚甲蓝是可溶性鸟苷酸环化酶和一氧化氮合酶的抑制剂。相比之下,原人参二醇组人参皂苷及其提纯的人参皂苷Rb1和Re对大鼠主动脉的血管张力或环鸟苷酸的产生没有影响。这些发现表明,原人参三醇组人参皂苷而非原人参二醇组人参皂苷可增强内皮细胞一氧化氮的释放,并可能有助于人参对心血管系统的有益作用。